80年代土耳其译制电影,80年代外国电影|80年代外国电影有哪些_80年代外国经典电影在线播放地址是多少？

[1]林麗卿,黃淑鉉,佘火標(biāo),等.CAAP-AF評(píng)分聯(lián)合心外膜脂肪厚度對(duì)Graves'病合并房顫患者導(dǎo)管消融術(shù)后早期復(fù)發(fā)的預(yù)測(cè)價(jià)值[J].福建醫(yī)藥雜志,2024,46(05):5-8.[doi:10.20148/j.fmj.2024.05.002]
　LIN Liqing,HUANG Shuxuan,SHE Huobiao,et al.Predictive value of CAAP-AF score combined with epicardial adipose tissue thickness for early recurrence after catheter ablation in patients with Graves'disease and atrial fibrillation[J].FUJIAN MEDICAL JOURNAL,2024,46(05):5-8.[doi:10.20148/j.fmj.2024.05.002]
點(diǎn)擊復(fù)制

CAAP-AF評(píng)分聯(lián)合心外膜脂肪厚度對(duì)Graves'病合并房顫患者導(dǎo)管消融術(shù)后早期復(fù)發(fā)的預(yù)測(cè)價(jià)值()
分享到：

《福建醫(yī)藥雜志》[ISSN:1002-2600/CN:35-1071/R]

卷:
46
期數(shù):
2024年05期
頁(yè)碼:
5-8
欄目:
臨床研究
出版日期:
2024-10-15

文章信息/Info

Title:
Predictive value of CAAP-AF score combined with epicardial adipose tissue thickness for early recurrence after catheter ablation in patients with Graves'disease and atrial fibrillation
文章編號(hào):
1002-2600(2024)05-0005-04
作者:
林麗卿; 黃淑鉉; 佘火標(biāo); 楊舒萍
福建醫(yī)科大學(xué)附屬漳州市醫(yī)院,漳州 363000
Author(s):
LIN Liqing;  HUANG Shuxuan;  SHE Huobiao;  YANG Shuping
Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou,Fujian 363000, China
關(guān)鍵詞:
CAAP-AF評(píng)分;  心外膜脂肪組織;  心房顫動(dòng);  導(dǎo)管消融術(shù);  Graves'病
Keywords:
CAAP-AF score;  epicardial adipose tissue;  atrial fibrillation;  catheter ablation;  Graves'disease
分類號(hào):
R541.7
DOI:
10.20148/j.fmj.2024.05.002
文獻(xiàn)標(biāo)志碼:
A
摘要:
目的 探討CAAP-AF評(píng)分聯(lián)合心外膜脂肪組織(EAT)厚度對(duì)Graves'病合并房顫患者導(dǎo)管消融術(shù)后早期復(fù)發(fā)的預(yù)測(cè)價(jià)值。方法 回顧性分析于我院行導(dǎo)管消融的Graves'病合并房顫患者41例,計(jì)算CAAP-AF評(píng)分并測(cè)量EAT厚度。按照術(shù)后患者有無復(fù)發(fā)分為早期復(fù)發(fā)組和無早期復(fù)發(fā)組。采用受試者工作特征(ROC)曲線分析CAAP-AF評(píng)分、EAT厚度及兩者聯(lián)合預(yù)測(cè)Graves'病合并房顫患者導(dǎo)管消融術(shù)后早期復(fù)發(fā)的價(jià)值。結(jié)果 導(dǎo)管消融術(shù)后10例患者出現(xiàn)早期復(fù)發(fā),31例無早期復(fù)發(fā)。多因素logistic回歸分析結(jié)果顯示,CAAP-AF評(píng)分和EAT厚度是Graves'病合并房顫患者導(dǎo)管消融術(shù)后早期復(fù)發(fā)的獨(dú)立影響因素。CAAP-AF評(píng)分、EAT厚度及兩者聯(lián)合預(yù)測(cè)Graves'病合并房顫患者導(dǎo)管消融術(shù)后早期復(fù)發(fā)的ROC曲線下面積分別為0.90、0.87、0.94。結(jié)論 CAAP-AF評(píng)分和EAT厚度是Graves'病合并房顫患者導(dǎo)管消融術(shù)后早期復(fù)發(fā)的獨(dú)立危險(xiǎn)因素,兩者聯(lián)合可提高對(duì)Graves'病合并房顫患者導(dǎo)管消融術(shù)后早期復(fù)發(fā)的預(yù)測(cè)價(jià)值。
Abstract:
Objective To investigate the predictive value of CAAP-AF score combined with epicardial adipose tissue(EAT)thickness for early recurrence after catheter ablation in patients with Graves'disease and atrial fibrillation. Methods A total of 41 patients with Graves'disease and atrial fibrillation who underwent catheter ablation in our Hospital were enrolled. The CAAP-AF score of each patient was calculated and the EAT thickness was measured. According to the postoperative follow-up outcomes, the patients were divided into early recurrence group and no early recurrence group. The receiver operating characteristic(ROC)curve was used to analyze the value of CAAP-AF score, EAT thickness and their combination in predicting early recurrence after catheter ablation. Results A total of 10 patients had early recurrence, and 31 patients had no early recurrence. The results of multivariate logistic regression analysis showed that CAAP-AF score and EAT thickness were independent influencing factors for early recurrence after catheter ablation in patients with Graves'disease and atrial fibrillation. The area under the ROC curve of CAAP-AF score, EAT thickness and the combination of CAAP-AF for predicting early recurrence after catheter ablation were 0.90, 0.87 and 0.94, respectively. Conclusion CAAP-AF score and EAT thickness are independent risk factors for early recurrence after catheter ablation in patients with Graves'disease and atrial fibrillation, and the combination of the two can improve the predictive value of early recurrence after catheter ablation.

參考文獻(xiàn)/References:

[1] 丁穎, 李玉宏. 超聲心動(dòng)圖評(píng)價(jià)甲亢并發(fā)房顫患者左心房結(jié)構(gòu)及功能改變[J]. 錦州醫(yī)科大學(xué)學(xué)報(bào), 2023, 44(4): 82-88.
[2] ANDRADE J G, AGUILAR M, ATZEMA C, et al. The 2020 Canadian cardiovascular society/Canadian heart rhythm society comprehensive guidelines for the management of atrial fibrillation [J]. Can J Cardiol, 2020, 36(12): 1847-948.
[3] JOGLAR J A, CHUNG M K, ARMBRUSTER A L, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines [J]. Circulation, 2024, 149(1): 1-156.
[4] CHEN J, MEI Z, YANG Y, et al. Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis [J]. BMC Cardiovasc Disord, 2022, 22(1): 264.
[5] WINKLE R A, JARMAN J W, MEAD R H, et al. Predicting atrial fibrillation ablation outcome: the CAAP-AF score [J]. Heart Rhythm, 2016, 13(11): 2119-2125.
[6] 中華醫(yī)學(xué)會(huì)心血管病學(xué)分會(huì), 中國(guó)生物醫(yī)學(xué)工程學(xué)會(huì)心律分會(huì). 心房顫動(dòng)診斷和治療中國(guó)指南[J]. 中華心血管病雜志, 2023, 51(6): 572-618.
[7] ANDERSON J L, JACOBS V, MAY H T, et al. Free thyroxine within the normal reference range predicts risk of atrial fibrillation [J]. J Cardiovasc Electrophysiol, 2020, 31(1): 18-29.
[8] WEN S, LIAO Y, KHURANA T S, et al. Reconsideration of the definition of blanking period and significance of early recurrences after catheter ablation of atrial fibrillation [J]. Curr Opin Cardiol, 2024, 39(1): 15-19.
[9] STEINBERG C, CHAMPAGNE J, DEYELL M W, et al. Prevalence and outcome of early recurrence of atrial tachyarrhythmias in the cryoballoon vs irrigated radiofrequency catheter ablation(CIRCA-DOSE)study[J]. Heart Rhythm, 2021, 18(9): 1463-1470.
[10] 楊澤漫, 唐立鴻, 黃淑萍. CAAP-AF評(píng)分和APPLE評(píng)分對(duì)心房顫動(dòng)合并心力衰竭患者導(dǎo)管消融術(shù)后復(fù)發(fā)的預(yù)測(cè)價(jià)值 [J]. 中國(guó)介入心臟病學(xué)雜志, 2020, 28(8): 430-435.
[11] SANHOURY M, MOLTRASIO M, TUNDO F, et al. Predictors of arrhythmia recurrence after balloon cryoablation of atrial fibrillation: the value of CAAP-AF risk scoring system [J]. J Interv Card Electrophysiol, 2017, 49(2): 129-135.
[12] GULDBERG E, DIEDERICHSEN S Z, HAUGAN K J, et al. Epicardial adipose tissue and subclinical incident atrial fibrilla-tion as detected by continuous monitoring: a cardiac magnetic resonance imaging study[J]. Int J Cardiovasc Imaging, 2024, 40(3): 591-599.
[13] TAKAHASHI N, ABE I, KIRA S, et al. Role of epicardial adipose tissue in human atrial fibrillation[J]. J Arrhythm, 2023, 39(2): 93-110.

備注/Memo

備注/Memo:
基金項(xiàng)目:福建省自然科學(xué)基金項(xiàng)目(2020J011306); 福建醫(yī)科大學(xué)附屬漳州市醫(yī)院博士工作室攀登課題資助項(xiàng)目(PDB202208)
通信作者:楊舒萍,Email:[email protected]
更新日期/Last Update: 2024-10-15